Lessons learned from COVID-19 for the post-antibiotic future
| dc.contributor.author | Wilson, Lindsay A | |
| dc.contributor.author | Rogers Van Katwyk, Susan | |
| dc.contributor.author | Fafard, Patrick | |
| dc.contributor.author | Viens, A. M | |
| dc.contributor.author | Hoffman, Steven J | |
| dc.date.accessioned | 2020-10-13T03:22:10Z | |
| dc.date.available | 2020-10-13T03:22:10Z | |
| dc.date.issued | 2020-10-08 | |
| dc.date.updated | 2020-10-13T03:22:10Z | |
| dc.description.abstract | Abstract Introduction COVID-19 has rapidly and radically changed the face of human health and social interaction. As was the case with COVID-19, the world is similarly unprepared to respond to antimicrobial resistance (AMR) and the challenges it will produce. COVID-19 presents an opportunity to examine how the international community might better respond to the growing AMR threat. Main body The impacts of COVID-19 have manifested in health system, economic, social, and global political implications. Increasing AMR will also present challenges in these domains. As seen with COVID-19, increasing healthcare usage and resource scarcity may lead to ethical dilemmas about prioritization of care; unemployment and economic downturn may disproportionately impact people in industries reliant on human interaction (especially women); and international cooperation may be compromised as nations strive to minimize outbreaks within their own borders. Conclusion AMR represents a slow-moving disaster that offers a unique opportunity to proactively develop interventions to mitigate its impact. The world’s attention is currently rightfully focused on responding to COVID-19, but there is a moral imperative to take stock of lessons learned and opportunities to prepare for the next global health emergency. | |
| dc.identifier.citation | Globalization and Health. 2020 Oct 08;16(1):94 | |
| dc.identifier.uri | https://doi.org/10.1186/s12992-020-00623-x | |
| dc.identifier.uri | https://doi.org/10.20381/ruor-25430 | |
| dc.identifier.uri | http://hdl.handle.net/10393/41206 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | The Author(s) | |
| dc.title | Lessons learned from COVID-19 for the post-antibiotic future |
